Gatekeeper Systems scores three major U.S. contracts this week
Gatekeeper has signed a C$180,000 upgrade agreement with a long-standing school district customer in California
Gatekeeper has also secured a project to provide video solutions and software subscriptions for a fleet of over 70 school buses in Nebraska, valued at approximately C$420,000
Gatekeeper Systems stock (TSXV:GSI) last traded at $0.70
A provider of intelligent video and data solutions for school buses, public transit, and smart cities, signed a series of significant contract wins across the United States, further expanding its footprint in the transportation technology sector.
In a landmark deal, Gatekeeper Systems (TSXV:GSI) has been awarded a contract by a transit agency in Oregon to equip its fleet with the company's advanced Mobile Data Collectors and a comprehensive suite of transit video solutions. The agency will also subscribe to Gatekeeper's AI-assisted video management platform, enabling enhanced video analytics and secure cloud-based storage. This new customer contract is valued at approximately US$1.4 million (C$1.9 million), with additional monthly recurring subscriptions exceeding US$50,000 per year over an initial five-year term, totaling approximately C$340,000.
In addition to the Oregon contract, Gatekeeper has signed an upgrade agreement with a long-standing school district customer in California. Under this contract, 46 existing buses will be upgraded, and 5 new buses will be outfitted with the company's latest school bus video systems. The district will also implement Gatekeeper's video management software for in-yard Wi-Fi-based video analysis and storage. The contract is valued at approximately US$131,000 (C$180,000), plus ongoing subscription services.
Further strengthening its presence in the Midwest, Gatekeeper has also secured a project to provide video solutions and software subscriptions for a fleet of over 70 school buses in Nebraska. The project, awarded through an original equipment manufacturer bus manufacturer, includes factory-installed Mobile Data Collectors and interior video systems, as specified by a major school bus transportation provider. This new customer engagement is valued at approximately C$420,000 (US$307,000), with additional recurring software subscription revenue.
Gatekeeper offers intelligent video and data solutions for the transportation industry.
Gatekeeper Systems stock (TSXV:GSI) last traded at $0.70 and has risen 22.81 per cent since the year began while growing 11.11 per cent since this time last year.
Join the discussion: Find out what everybody's saying about this micro-cap tech stock on the Gatekeeper Systems Inc. Bullboard and check out Stockhouse's stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
How major US stock indexes fared Wednesday, 8/13/2025
U.S. stocks notched some more records as a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.3% Wednesday. The Dow Jones Industrial Average climbed 1%, while the Nasdaq added 0.1% to its record set the day before. Treasury yields eased, as expectations reached a virtual consensus that the Federal Reserve will cut its main interest rate for the first time this year at its next meeting in September. On Wednesday: The S&P 500 rose 20.82 points, or 0.3%, to 6,466.58. The Dow Jones Industrial Average rose 463.66 points, or 1%, to 44,922.27. The Nasdaq composite rose 31.24 points, or 0.1%, to 21,713.14. The Russell 2000 index of smaller companies rose 45.28 points, or 2%, to 2,228.06. For the week: The S&P 500 is up 77.13 points, or 1.2%. The Dow is up 746.66 points, or 1.7%. The Nasdaq is up 263.12 points, or 1.2%. The Russell 2000 is up 109.64 points, or 4.9%. For the year: The S&P 500 is up 584.95 points, or 9.9%. The Dow is up 2,378.05 points, or 5.6%. The Nasdaq is up 2,402.35 points, or 12.4%. The Russell 2000 is up 97.90 points, or 4.4%.
Cision Canada
3 hours ago
- Cision Canada
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
SASKATOON, SK, Aug. 15, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche") of its non-brokered private placement (the " Offering") of units of the Company (each a " Unit") for up to CAD $1,000,000. Under the Second Tranche of the Offering, a further 140,845 Units were issued for aggregate gross proceeds of CAD $100,000. The aggregate gross proceeds raised in the Second Tranche and first tranche of the Offering (which closed on July 29, 2025) (the " First Tranche") is approximately $0.42 million. The Company has issued a total of 591,126 Units each priced at $0.71 per Unit in the First Tranche and the Second Tranche. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (each Common Share purchase warrant, a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of 5 consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued under the First Tranche are subject to a hold period expiring November 30, 2025, and all securities issued under the Second Tranche of the Offering are subject to a hold period expiring December 16, 2025, in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
CTV News
4 hours ago
- CTV News
CTV National News: Trump targeting semi-conductor industry
Watch U.S. President Donald Trump dropped another trade threat on his way to Alaska. Rachel Aiello has the details.
